Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Nicoleta Iftode"'
Autor:
Maria Ilinca Trifonescu, Violeta Molagic, Catalin Tiliscan, Oana Alexandra Ganea, Gelal Aytu Turan, Laurentiu Stratan, Angelica Visan, Nicoleta Iftode, Sorin Stefan Arama, Victoria Arama
Publikováno v:
Romanian Journal of Infectious Diseases, Vol 24, Iss 4, Pp 203-206 (2021)
Introduction. COVID-19 is a viral infection with a variable clinical spectrum, ranging from asymptomatic carrier state to severe pneumonia. It is associated with a variety ofcomplications, including musculo-skeletal abnormalities. Whereas myalgia is
Externí odkaz:
https://doaj.org/article/aa3380909de64e999c8537ce74ce4ef5
Publikováno v:
Romanian Journal of Internal Medicine, Vol 58, Iss 4, Pp 199-208 (2020)
Human herpesvirus 8 (HHV8), also known as Kaposi sarcoma-associated herpesvirus (KSHV), is one of the few pathogens recognized as direct carcinogen, being involved in the pathogenesis of Kaposi sarcoma, primary effusion lymphoma and multicentric Cast
INFLUENCE OF TOCILIZUMAB ON THE OUTCOME OF PATIENTS WITH COVID-19. RETROSPECTIVE OBSERVATIONAL STUDY
Autor:
Nicoleta Iftode, Victoria Aramă, Mirela Dumitriţa Ilie, Bogdan Ovidiu Popescu, Georgiana Sandu, Teodora Bunea, Eugenia Irene Davidescu, Laurenţiu Stratan, Irina Odajiu
Publikováno v:
FARMACIA. 68:792-799
Cytokine storm seems to be one of the main culprits for developing a severe form of COVID-19, IL-6 being one of its basic components Therefore, currently, tocilizumab is widely studied as a powerful treatment in patients with severe forms of COVID-19
Autor:
Nicoleta Iftode, Cătălin Apostolescu
Publikováno v:
Infectio.ro. 2
Autor:
Iftode, Nicoleta1 nicoleta.iftode@yahoo.com, Apostolescu, Cătălin1,2
Publikováno v:
Infectio.ro. 2017, Vol. 50 Issue 2, p34-36. 3p.
Publikováno v:
Romanian Journal of Internal Medicine; Dec2020, Vol. 58 Issue 4, p199-208, 10p
Autor:
DAVIDESCU, EUGENIA IRENE, ODAJIU, IRINA, ILIE, MIRELA DUMITRIȚA, BUNEA, TEODORA, SANDU, GEORGIANA, STRATAN, LAURENȚIU, IFTODE, NICOLETA, ARAMĂ, VICTORIA, POPESCU, BOGDAN OVIDIU
Publikováno v:
Farmacia; 2020, Vol. 68 Issue 5, p792-799, 8p